Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 19/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 13/20 | 0.44 |
| ▸ | PIK3CB | P42338 | 12/20 | 0.44 |
| ▸ | PIK3CG | P48736 | 12/20 | 0.44 |
| ▸ | PIK3R2 | O00459 | 1/20 | 0.44 |
| ▸ | PIK3R1 | P27986 | 10/20 | 0.41 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13190186 | 0.90 | PIK3CD (0.51) | PIK3CDPIK3CAPIK3CBPIK3CGPIK3R2 | |
| SCHEMBL470331 | 0.81 | PIK3CD (0.47) | PIK3CDPIK3CAPIK3CBPIK3CGPIK3R2 | |
| SCHEMBL10280417 | 0.76 | PIK3CD (0.49) | PIK3CDPIK3CAPIK3CBPIK3CGPIK3R2 | |
| SCHEMBL470096 | 0.75 | PIK3CD (0.61) | PIK3CDPIK3CAPIK3CBPIK3CGPIK3R2 | |
| SCHEMBL457776 | 0.75 | PIK3CD (0.61) | PIK3CDPIK3CAPIK3CBPIK3CGPIK3R2 | |
| SCHEMBL719755 | 0.74 | PIK3CD (0.60) | PIK3CDPIK3CAPIK3CBPIK3CGPIK3R2 | |
| SCHEMBL459270 | 0.74 | PIK3CD (0.60) | PIK3CDPIK3CAPIK3CBPIK3CGPIK3R2 | |
| SCHEMBL714978 | 0.73 | PIK3CD (0.55) | PIK3CDPIK3CAPIK3CBPIK3CGPIK3R2 | |
| SCHEMBL714987 | 0.72 | PIK3CD (0.80) | PIK3CDPIK3CAPIK3CBPIK3CGPIK3R2 | |
| SCHEMBL459118 | 0.72 | PIK3CD (0.80) | PIK3CDPIK3CAPIK3CBPIK3CGPIK3R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012032065-A1 | INDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF INFLUENZA VIRUS INFECTION | GLAXO GROUP LIMITED (GB) | 2012-03-15 | — | — | WO | disclosed |